ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 128 filers reported holding ANAPTYSBIO INC in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $680,684 | -21.4% | 37,900 | -11.0% | 0.00% | 0.0% |
| Q2 2023 | $866,484 | +7.9% | 42,600 | +15.4% | 0.00% | 0.0% |
| Q1 2023 | $802,944 | -36.7% | 36,900 | -9.8% | 0.00% | 0.0% |
| Q4 2022 | $1,267,491 | +23.9% | 40,900 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $1,023,000 | +28.8% | 40,100 | +2.6% | 0.00% | 0.0% |
| Q2 2022 | $794,000 | -24.2% | 39,100 | -7.6% | 0.00% | 0.0% |
| Q1 2022 | $1,047,000 | -23.1% | 42,300 | +7.9% | 0.00% | 0.0% |
| Q4 2021 | $1,362,000 | +28.1% | 39,200 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,063,000 | +4.6% | 39,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,016,000 | -15.2% | 39,200 | -29.5% | 0.00% | 0.0% |
| Q1 2021 | $1,198,000 | +0.3% | 55,600 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,195,000 | +48.4% | 55,600 | +1.8% | 0.00% | 0.0% |
| Q3 2020 | $805,000 | -34.0% | 54,600 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,220,000 | +82.1% | 54,600 | +15.2% | 0.00% | 0.0% |
| Q1 2020 | $670,000 | -9.6% | 47,400 | +3.9% | 0.00% | 0.0% |
| Q4 2019 | $741,000 | -53.6% | 45,600 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $1,596,000 | -37.4% | 45,600 | +0.9% | 0.00% | -33.3% |
| Q2 2019 | $2,550,000 | +2.4% | 45,200 | +32.6% | 0.00% | 0.0% |
| Q1 2019 | $2,491,000 | +31.5% | 34,100 | +14.8% | 0.00% | +50.0% |
| Q4 2018 | $1,895,000 | -36.0% | 29,700 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $2,963,000 | +45.3% | 29,700 | +3.5% | 0.00% | +50.0% |
| Q2 2018 | $2,039,000 | -4.5% | 28,700 | +40.0% | 0.00% | -33.3% |
| Q1 2018 | $2,134,000 | +9.2% | 20,500 | +5.7% | 0.00% | +50.0% |
| Q4 2017 | $1,954,000 | +453.5% | 19,400 | +92.1% | 0.00% | – |
| Q3 2017 | $353,000 | +45.9% | 10,100 | 0.0% | 0.00% | – |
| Q2 2017 | $242,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $371,500,000 | 60.25% |
| Cormorant Asset Management, LP | 1,251,485 | $126,050,000 | 13.20% |
| BVF INC/IL | 594,397 | $59,868,000 | 7.22% |
| VHCP Management II, LLC | 282,550 | $28,458,000 | 6.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 812,484 | $81,833,000 | 3.22% |
| Iguana Healthcare Management, LLC | 40,000 | $4,029,000 | 2.62% |
| Perceptive Advisors | 756,387 | $76,183,000 | 2.52% |
| Cormorant Asset Management, LP | 135,000 | $13,597,000 | 1.42% |
| EAM Global Investors LLC | 21,734 | $2,189,000 | 1.12% |
| PFM Health Sciences, LP | 425,896 | $42,896,000 | 1.02% |